| Date Filed | Type | Description |
| 05/11/2023 |
4
| Yanai Shlomo (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0
Exercised 80,128 restricted stock units
@ $0 |
|
| 05/05/2023 |
4
| Yanai Shlomo (Director) has filed a Form 4 on Philip Morris International Inc.|
Txns:
| Granted 1,812 shares
@ $96.58, valued at
$175k
|
|
| 05/10/2022 |
4
| Yanai Shlomo (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Exercised 35,406 restricted stock units
@ $0
Granted 80,128 restricted stock units
@ $0 |
|
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2020 |
4
| Yanai Shlomo (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Exercised 7,522 restricted stock units
@ $0 |
|
| 05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2019 |
4
| Yanai Shlomo (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 28,506 options
@ $4.76, valued at
$135.7k
Granted 7,522 restricted stock units
@ $0 |
|
| 12/16/2019 |
3
| Yanai Shlomo (Director) has filed a Form 3 on Amneal Pharmaceuticals, Inc. |
| 12/05/2019 |
4
| Yanai Shlomo (Director) has filed a Form 4 on CAMBREX CORP|
Txns:
| Sold 35,796 shares
@ $60, valued at
$2.1M
Exercised 6,371 options to buy
@ $12.9, valued at
$82.2k
Exercised 3,863 options to buy
@ $21.7, valued at
$83.8k
Exercised 2,140 options to buy
@ $41.225, valued at
$88.2k
Exercised 1,613 options to buy
@ $45.12, valued at
$72.8k
Exercised 1,577 options to buy
@ $58.98, valued at
$93k
Exercised 1,980 options to buy
@ $53.7, valued at
$106.3k
Exercised 2,766 options to buy
@ $40.06, valued at
$110.8k
|
|
| 06/24/2019 |
4
| Yanai Shlomo (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 126,050 options to buy
@ $3, valued at
$378.2k
|
|
| 05/09/2019 |
4
| Yanai Shlomo (Director) has filed a Form 4 on W R GRACE & CO|
Txns:
| Granted 1,532 shares
@ $0 |
|
| 04/25/2019 |
4
| Yanai Shlomo (Director) has filed a Form 4 on CAMBREX CORP|
Txns:
| Granted 2,247 shares
@ $0
Granted 2,766 options to buy
@ $40.06, valued at
$110.8k
|
|
| 06/12/2018 |
4
| Yanai Shlomo (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 54,348 shares
@ $2.76, valued at
$150k
|
|
| 06/12/2018 |
3
| Yanai Shlomo (Director) has filed a Form 3 on PDL BIOPHARMA, INC. |
| 05/11/2018 |
4
| Yanai Shlomo (Director) has filed a Form 4 on W R GRACE & CO|
Txns:
| Granted 1,478 shares
@ $0 |
|
| 05/11/2018 |
3
| Yanai Shlomo (Director) has filed a Form 3 on W R GRACE & CO |
| 04/30/2018 |
4
| Yanai Shlomo (Director) has filed a Form 4 on CAMBREX CORP|
Txns:
| Granted 1,397 shares
@ $0
Granted 1,980 options to buy
@ $53.7, valued at
$106.3k
|
|
| 07/14/2017 |
4
| Yanai Shlomo (Director) has filed a Form 4 on Exela Technologies, Inc.|
Txns:
| Disposed/sold 29,500 shares
@ $0 |
|
| 05/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/31/2016 |
4
| Yanai Shlomo (Director) has filed a Form 4 on Sagent Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 742 shares
@ $21.75, valued at
$16.1k
Disposed/sold 8,556 restricted stock units
@ $21.75, valued at
$186.1k
Disposed/sold 2,228 restricted stock units
@ $21.75, valued at
$48.5k
|
|
| 05/23/2016 |
4
| Yanai Shlomo (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Granted 3,263 restricted stock units
@ $0 |
|
| 05/06/2016 |
4
| Yanai Shlomo (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Exercised 924 shares
@ $95.7, valued at
$88.4k
Paid exercise price by delivering 481 shares
@ $95.7, valued at
$46k
Exercised 924 restricted stock units
@ $0 |
|
| 04/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/18/2016 |
4
| Yanai Shlomo (Director) has filed a Form 4 on Sagent Pharmaceuticals, Inc.|
Txns:
| Exercised 742 restricted stock units
@ $0 |
|
| 04/29/2013 |
4
| Yanai Shlomo (Director) has filed a Form 4 on CAMBREX CORP|
Txns:
| Granted 3,956 shares
@ $0
Exercised 6,371 options to buy
@ $12.9, valued at
$82.2k
|
|
| 11/29/2012 |
4
| Yanai Shlomo (Director) has filed a Form 4 on CAMBREX CORP|
Txns:
| Granted 1,695 shares
@ $0 |
|
| 11/29/2012 |
3
| Yanai Shlomo (Director) has filed a Form 3 on CAMBREX CORP |